URMC / Research / Health Research /Clinical Trials / Study Details

UMMY19160/Hyperbaric Oxygen/ Omar Aljitawi

Research Question:
Is treatment in a hyperbaric oxygen chamber safe and effective for patients with a type of cancer called multiple myeloma?

Basic Study Information

Purpose:
Subjects with multiple myeloma (MM) who are considered eligible for high-dose therapy and autologous stem cell transplantation by the transplant team at WCI will be enrolled in the study.

Study Reference #: STUDY00006189

Lead Researcher (Principal Investigator)

Lead Researcher: Omar Aljitawi

Study Contact Information

Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu

Additional Study Details

Contact This Study

First Name *

This field is required

Middle Name

Last Name *

This field is required

Phone Number

I agree to be contacted by The University of Rochester Medical Center regarding participation in this study. *

You must agree to be contacted to continue.

Please call me during the day.

Please call me during the evening.

Message

Return to Search

Research

UR Health Research